Where Tech Meets Bio

Where Tech Meets Bio

Share this post

Where Tech Meets Bio
Where Tech Meets Bio
The State of A.I. Drug Discovery and Its Future
Copy link
Facebook
Email
Notes
More

The State of A.I. Drug Discovery and Its Future

Implications for small molecule, vaccine and antibody drug development

Andrii Buvailo's avatar
Andrii Buvailo
Mar 23, 2023
∙ Paid
4

Share this post

Where Tech Meets Bio
Where Tech Meets Bio
The State of A.I. Drug Discovery and Its Future
Copy link
Facebook
Email
Notes
More
Share

(This post is sponsored by Syntekabio)

Artificial intelligence (A.I.) and big data in a synergistic integration have led to promising results in new drug development by drastically reducing cost and time. This trend in the biopharmaceutical market has emerged as a new industry standard as startups—each with distinctive core A.I. algorithm—fiercely compet…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 BiopharmaTrend (BPT Analytics Ltd)
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More